Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellular Senescence | 4 | 2025 | 189 | 0.640 |
Why?
|
| Vascular Diseases | 3 | 2023 | 243 | 0.500 |
Why?
|
| Vascular Stiffness | 4 | 2025 | 494 | 0.480 |
Why?
|
| Flavonols | 2 | 2025 | 18 | 0.450 |
Why?
|
| Exercise Tolerance | 2 | 2025 | 279 | 0.240 |
Why?
|
| Aorta | 2 | 2025 | 417 | 0.240 |
Why?
|
| Interferon Regulatory Factors | 1 | 2025 | 39 | 0.230 |
Why?
|
| Arteries | 2 | 2023 | 269 | 0.230 |
Why?
|
| Flavonoids | 1 | 2025 | 85 | 0.230 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2025 | 127 | 0.230 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2024 | 17 | 0.220 |
Why?
|
| Toll-Like Receptors | 1 | 2025 | 185 | 0.220 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2024 | 26 | 0.220 |
Why?
|
| Sympathetic Nervous System | 1 | 2025 | 182 | 0.220 |
Why?
|
| Smoking Water Pipes | 1 | 2023 | 9 | 0.220 |
Why?
|
| Water Pipe Smoking | 1 | 2023 | 9 | 0.210 |
Why?
|
| Spermidine | 1 | 2024 | 19 | 0.210 |
Why?
|
| Endothelial Cells | 6 | 2025 | 785 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2025 | 561 | 0.210 |
Why?
|
| Endothelium, Vascular | 3 | 2025 | 927 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2025 | 362 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2024 | 71 | 0.200 |
Why?
|
| Elastin | 1 | 2023 | 78 | 0.200 |
Why?
|
| NAD | 1 | 2023 | 77 | 0.200 |
Why?
|
| Sarcoma, Ewing | 1 | 2024 | 97 | 0.200 |
Why?
|
| Postmenopause | 1 | 2025 | 366 | 0.200 |
Why?
|
| Vaping | 1 | 2023 | 60 | 0.200 |
Why?
|
| Pulse Wave Analysis | 4 | 2025 | 272 | 0.190 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2023 | 103 | 0.190 |
Why?
|
| Aging | 4 | 2025 | 1864 | 0.190 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 135 | 0.190 |
Why?
|
| Vasodilation | 1 | 2025 | 499 | 0.180 |
Why?
|
| Reactive Oxygen Species | 4 | 2025 | 622 | 0.170 |
Why?
|
| Muscle, Skeletal | 3 | 2025 | 1724 | 0.170 |
Why?
|
| Resistance Training | 1 | 2023 | 164 | 0.170 |
Why?
|
| Dementia | 1 | 2023 | 259 | 0.160 |
Why?
|
| Antioxidants | 1 | 2023 | 584 | 0.160 |
Why?
|
| Inflammation | 3 | 2025 | 2837 | 0.160 |
Why?
|
| Motor Activity | 1 | 2024 | 718 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.130 |
Why?
|
| Mice | 7 | 2025 | 17787 | 0.110 |
Why?
|
| Nitric Oxide | 3 | 2023 | 915 | 0.110 |
Why?
|
| Oxidative Stress | 3 | 2025 | 1317 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2111 | 0.100 |
Why?
|
| Brachial Artery | 2 | 2025 | 205 | 0.100 |
Why?
|
| Cross-Over Studies | 2 | 2023 | 564 | 0.090 |
Why?
|
| Animals | 7 | 2025 | 36940 | 0.080 |
Why?
|
| Humans | 13 | 2025 | 137585 | 0.070 |
Why?
|
| Mitochondria | 2 | 2025 | 948 | 0.070 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2025 | 6 | 0.060 |
Why?
|
| THP-1 Cells | 1 | 2025 | 22 | 0.060 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 39 | 0.060 |
Why?
|
| Male | 7 | 2025 | 67762 | 0.060 |
Why?
|
| Aniline Compounds | 1 | 2025 | 102 | 0.060 |
Why?
|
| Hand Strength | 1 | 2025 | 123 | 0.060 |
Why?
|
| Premenopause | 1 | 2025 | 131 | 0.060 |
Why?
|
| Aged | 4 | 2025 | 23961 | 0.050 |
Why?
|
| Standard of Care | 1 | 2024 | 72 | 0.050 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2023 | 9 | 0.050 |
Why?
|
| Respiratory Muscles | 1 | 2023 | 33 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2023 | 116 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2023 | 185 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 242 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2023 | 132 | 0.050 |
Why?
|
| Middle Aged | 4 | 2025 | 33479 | 0.050 |
Why?
|
| Monocytes | 1 | 2025 | 563 | 0.050 |
Why?
|
| Female | 6 | 2025 | 73304 | 0.050 |
Why?
|
| DNA Damage | 1 | 2024 | 420 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2025 | 513 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 267 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 872 | 0.040 |
Why?
|
| Nicotine | 1 | 2023 | 334 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2024 | 324 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2025 | 1759 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2023 | 317 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 916 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 931 | 0.030 |
Why?
|
| Adult | 3 | 2025 | 37929 | 0.030 |
Why?
|
| Cytokines | 1 | 2025 | 2085 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2025 | 4193 | 0.030 |
Why?
|
| Young Adult | 2 | 2023 | 13209 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2475 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3412 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 2553 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4295 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 5079 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 7635 | 0.020 |
Why?
|
| Adolescent | 1 | 2023 | 21513 | 0.010 |
Why?
|